首页> Oncotarget> Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306).

Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306).

导出 OA

翻译打印收藏纠错

第一作者： Dominik Paul,Modest

第一单位： Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.;German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg, Germany.

作者： Dominik Paul,Modest ^[1] ; Sebastian,Stintzing ^[1] ; Ludwig Fischer,von Weikersthal ^[2] ; Thomas,Decker ^[3] ; Alexander,Kiani ^[4] ; Ursula,Vehling-Kaiser ^[5] ; Salah-Eddin,Al-Batran ^[6] ; Tobias,Heintges ^[7] ; Christoph,Kahl ^[8] ; Gernot,Seipelt ^[9] ; Frank,Kullmann ^[10] ; Werner,Scheithauer ^[11] ; Markus,Moehler ^[12] ; Julian Walter,Holch ^[1] ; Jobst Christian,von Einem ^[1] ; Swantje,Held ^[13] ; Volker,Heinemann ^[1]

作者单位： Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.;German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg, Germany. ^[1] Gesundheitszentrum St. Marien, Amberg, Germany. ^[2] Oncological Practice, Ravensburg, Germany. ^[3] Medizinische Klinik IV, Klinikum Bayreuth, Bayreuth, Germany. ^[4] Oncological Practice, Landshut, Germany. ^[5] Department of Hematology and Oncology, Krankenhaus Nordwest Frankfurt/Main, Frankfurt, Germany. ^[6] Department of Medicine II, Städtisches Klinikum Neuss, Neuss, Germany. ^[7] Haematology and Oncology, Staedtisches Klinikum Magdeburg, Magdeburg, Germany. ^[8] Oncological Practice, Bad Soden, Germany. ^[9] Department of Medicine I, Klinikum Weiden, Weiden in der Oberpfalz, Germany. ^[10] Department of Internal Medicine I & Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria. ^[11] Medical Department 1, Johannes-Gutenberg Universität Mainz, Mainz, Germany.;University Cancer Center Frankfurt/Mainz and German Cancer Consortium (DKTK), Heidelberg, Germany. ^[12] ClinAssess GmbH, Leverkusen, Germany. ^[13]

关键词 EGFR antibody bevacizumab colorectal cancer sequential therapy tumor sidedness

DOI 10.18632/oncotarget.22396

PMID 29285289

发布时间 2022-03-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交